SCHEMBL28756807

SCHEMBL28756807

CC(O)CC(N)(c1ccccc1)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.39
CYP1A2 P05177 1/20 0.39
CHRM3 P20309 5/20 0.37
GRIN1 Q05586 4/20 0.36
GRIN2A Q12879 4/20 0.36
GRIN2D O15399 3/20 0.36
GRIN2C Q14957 3/20 0.36
GRIN2B Q13224 2/20 0.36
CHRM2 P08172 3/20 0.35
CHRM1 P11229 3/20 0.35
KCNH2 Q12809 2/20 0.35
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
HRH1 P35367 1/20 0.34
SCN1A P35498 1/20 0.34
KMT2A Q03164 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16047199 0.77 KCNN4 (0.39) CYP2D6CHRM3CHRM2CHRM1KCNH2
SCHEMBL28137313 0.72 CYP2C19 (0.47) CYP2D6CYP1A2CHRM3CHRM2CHRM1
SCHEMBL7073060 0.72 CYP1A2 (0.43) CYP2D6CYP1A2CHRM3GRIN1GRIN2A
SCHEMBL27630319 0.72 CYP2D6 (0.43) CYP2D6CYP1A2CHRM3GRIN1GRIN2A
SCHEMBL8816057 0.70 GRIN1 (0.47) CYP2D6CYP1A2CHRM3GRIN1GRIN2A
SCHEMBL4399833 0.69 TAAR1 (0.50) CYP2D6CYP1A2GRIN1GRIN2AGRIN2D
SCHEMBL4399836 0.69 TAAR1 (0.50) CYP2D6CYP1A2GRIN1GRIN2AGRIN2D
SCHEMBL10952717 0.69 CYP2C19 (0.44) CYP2D6CYP1A2GRIN1GRIN2AGRIN2D
SCHEMBL113841 0.69 TAAR1 (0.50) CYP2D6CYP1A2GRIN1GRIN2AGRIN2D
Ammonia Solution, Strong SCHEMBL27739613 0.67 TAAR1 (0.48) CYP2D6CYP1A2GRIN1GRIN2AGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1735592-A Hydroxyethylamine derivatives for the treatment of alzheimer's disease GLAXO GROUP LTD (GB) 2006-02-15 CN disclosed